These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 15814777)

  • 1. Tumoral calcinosis: a look into the metabolic mirror of phosphate homeostasis.
    de Beur SM
    J Clin Endocrinol Metab; 2005 Apr; 90(4):2469-71. PubMed ID: 15814777
    [No Abstract]   [Full Text] [Related]  

  • 2. [Familial tumoral calcinosis with hyperphosphatemia is heterogeneous and associated with mutations in GALNT3 or FGF-23].
    Dereure O
    Ann Dermatol Venereol; 2006 Apr; 133(4):408. PubMed ID: 16733465
    [No Abstract]   [Full Text] [Related]  

  • 3. A novel GALNT3 mutation in a pseudoautosomal dominant form of tumoral calcinosis: evidence that the disorder is autosomal recessive.
    Ichikawa S; Lyles KW; Econs MJ
    J Clin Endocrinol Metab; 2005 Apr; 90(4):2420-3. PubMed ID: 15687324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of mutant UDP-N-acetyl-alpha-D-galactosamine-polypeptide N-acetylgalactosaminyltransferase 3 in regulating serum intact fibroblast growth factor 23 and matrix extracellular phosphoglycoprotein in heritable tumoral calcinosis.
    Garringer HJ; Fisher C; Larsson TE; Davis SI; Koller DL; Cullen MJ; Draman MS; Conlon N; Jain A; Fedarko NS; Dasgupta B; White KE
    J Clin Endocrinol Metab; 2006 Oct; 91(10):4037-42. PubMed ID: 16868048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A homozygous missense mutation in human KLOTHO causes severe tumoral calcinosis.
    Ichikawa S; Imel EA; Kreiter ML; Yu X; Mackenzie DS; Sorenson AH; Goetz R; Mohammadi M; White KE; Econs MJ
    J Musculoskelet Neuronal Interact; 2007; 7(4):318-9. PubMed ID: 18094491
    [No Abstract]   [Full Text] [Related]  

  • 6. A novel recessive mutation of fibroblast growth factor-23 in tumoral calcinosis.
    Masi L; Gozzini A; Franchi A; Campanacci D; Amedei A; Falchetti A; Franceschelli F; Marcucci G; Tanini A; Capanna R; Brandi ML
    J Bone Joint Surg Am; 2009 May; 91(5):1190-8. PubMed ID: 19411468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An FGF23 missense mutation causes familial tumoral calcinosis with hyperphosphatemia.
    Benet-Pagès A; Orlik P; Strom TM; Lorenz-Depiereux B
    Hum Mol Genet; 2005 Feb; 14(3):385-90. PubMed ID: 15590700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel homozygous missense mutation in FGF23 causes Familial Tumoral Calcinosis associated with disseminated visceral calcification.
    Chefetz I; Heller R; Galli-Tsinopoulou A; Richard G; Wollnik B; Indelman M; Koerber F; Topaz O; Bergman R; Sprecher E; Schoenau E
    Hum Genet; 2005 Nov; 118(2):261-6. PubMed ID: 16151858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel recessive mutation in fibroblast growth factor-23 causes familial tumoral calcinosis.
    Larsson T; Yu X; Davis SI; Draman MS; Mooney SD; Cullen MJ; White KE
    J Clin Endocrinol Metab; 2005 Apr; 90(4):2424-7. PubMed ID: 15687325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperphosphatemic familial tumoral calcinosis: genetic models of deficient FGF23 action.
    Folsom LJ; Imel EA
    Curr Osteoporos Rep; 2015 Apr; 13(2):78-87. PubMed ID: 25656441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Familial tumoral calcinosis and the role of O-glycosylation in the maintenance of phosphate homeostasis.
    Chefetz I; Sprecher E
    Biochim Biophys Acta; 2009 Sep; 1792(9):847-52. PubMed ID: 19013236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reply to ultrastructural study of the clinically uninvolved skin in familial tumoral calcinosis caused by mutations in GALNT3.
    Bergman R; Topaz O; Iancu TC; Sprecher E
    Am J Dermatopathol; 2006 Aug; 28(4):372-3. PubMed ID: 16871046
    [No Abstract]   [Full Text] [Related]  

  • 13. Identification of a recurrent mutation in GALNT3 demonstrates that hyperostosis-hyperphosphatemia syndrome and familial tumoral calcinosis are allelic disorders.
    Frishberg Y; Topaz O; Bergman R; Behar D; Fisher D; Gordon D; Richard G; Sprecher E
    J Mol Med (Berl); 2005 Jan; 83(1):33-8. PubMed ID: 15599692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in tumoral calcinosis have been principally concerned with the discovery of genetic mutations responsible for this disorder.
    Slavin RE
    Am J Dermatopathol; 2006 Aug; 28(4):374-5. PubMed ID: 16871047
    [No Abstract]   [Full Text] [Related]  

  • 15. Tumoral calcinosis presenting with eyelid calcifications due to novel missense mutations in the glycosyl transferase domain of the GALNT3 gene.
    Ichikawa S; Imel EA; Sorenson AH; Severe R; Knudson P; Harris GJ; Shaker JL; Econs MJ
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4472-5. PubMed ID: 16940445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations in GALNT3, encoding a protein involved in O-linked glycosylation, cause familial tumoral calcinosis.
    Topaz O; Shurman DL; Bergman R; Indelman M; Ratajczak P; Mizrachi M; Khamaysi Z; Behar D; Petronius D; Friedman V; Zelikovic I; Raimer S; Metzker A; Richard G; Sprecher E
    Nat Genet; 2004 Jun; 36(6):579-81. PubMed ID: 15133511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polypeptide GalNAc-transferase T3 and familial tumoral calcinosis. Secretion of fibroblast growth factor 23 requires O-glycosylation.
    Kato K; Jeanneau C; Tarp MA; Benet-Pagès A; Lorenz-Depiereux B; Bennett EP; Mandel U; Strom TM; Clausen H
    J Biol Chem; 2006 Jul; 281(27):18370-7. PubMed ID: 16638743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel GALNT3 mutations causing hyperostosis-hyperphosphatemia syndrome result in low intact fibroblast growth factor 23 concentrations.
    Ichikawa S; Guigonis V; Imel EA; Courouble M; Heissat S; Henley JD; Sorenson AH; Petit B; Lienhardt A; Econs MJ
    J Clin Endocrinol Metab; 2007 May; 92(5):1943-7. PubMed ID: 17311862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two novel nonsense mutations in GALNT3 gene are responsible for familial tumoral calcinosis.
    Barbieri AM; Filopanti M; Bua G; Beck-Peccoz P
    J Hum Genet; 2007; 52(5):464-468. PubMed ID: 17351710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperphosphataemic familial tumoral calcinosis: case report of a rare and challenging disease.
    Guerra MG; Videira T; de Fonseca D; Vieira R; Dos Santos J; Pinto S
    Scand J Rheumatol; 2020 Jan; 49(1):80-81. PubMed ID: 31213107
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.